Dataset from A Multicenter, Open Label, Phase I/Randomized II Study to Evaluate Safety, Pharmacokinetics and Efficacy of BIBF 1120 in Comparison With Sorafenib for Advanced Hepatocellular Carcinoma Patients in Asia.
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00003581
下载链接
链接失效反馈官方服务：
资源简介：
This study is to evaluate the safety, appropriate dose, and efficacy of BIBF 1120 in liver cancer patients
创建时间：
2025-02-22
